Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

14.26
Delayed Data
As of 10:16am ET
 +0.04 / +0.28%
Today’s Change
11.25
Today|||52-Week Range
19.62
+3.11%
Year-to-Date

Today’s Trading

Previous close14.22
Today’s open14.51
Day’s range14.13 - 14.51
Volume36,639
Average volume (3 months)792,869
Market cap$1.5B
Dividend yield--
Data as of 10:16am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-4.14%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book9.42

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-0.20-0.50%
AXONAxovant Sciences Ltd-0.03-0.20%
AERIAerie Pharmaceutical...+0.75+1.64%
SUPNSupernus Pharmaceuti...+0.85+2.99%
Data as of 10:31am ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs